Vinn
just wanted your views...as im a newbie to investing.
would you call Mesoblast a 'slam dunk' investment, in that all of its applications will reach commercialisation.
also, what is the likelihood that based on phase 1 & 2 trial results, the crucial Phase 3 trials for revascor and Neofuse and the bone morrow product fail or get rejected by the FDA?one broker report has given the chance of commercialisation 75% - how likely is a 25% failure?
MT79
- Forums
- ASX - By Stock
- MSB
- this invest. company is well aware ...
this invest. company is well aware ..., page-3
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.035(3.57%) |
Mkt cap ! $1.167B |
Open | High | Low | Value | Volume |
$1.01 | $1.04 | 99.0¢ | $1.966M | 1.927M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 6631 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 61242 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 124993 | 1.010 |
11 | 133013 | 1.005 |
11 | 148189 | 1.000 |
4 | 125280 | 0.995 |
8 | 62230 | 0.990 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 61242 | 27 |
1.025 | 121108 | 15 |
1.030 | 63712 | 9 |
1.035 | 41304 | 6 |
1.040 | 42599 | 4 |
Last trade - 10.58am 16/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online